The global knee pain management market size is expected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the surge in the frequency of sports injuries, the aging population, and the global patient pool are all driving global demand for knee pain management. High prevalence and incidence of osteoarthritis and rheumatoid arthritis among adult and geriatric populations.
Knee pain is a common ailment caused by the knee's bone structure. It is closely correlated with age. The location of knee pain is determined by the injured area. Limping owing to discomfort, trouble walking, climbing stairs, locking of the knee, redness, swelling, and inability to extend the knee are all symptoms of knee pain. Knee discomfort in young people is related to the overuse of knee joints as a result of physical activity or sports. It is caused by the wear and tear of the knee joint caused by osteoarthritis and rheumatoid arthritis in the elderly population.
Patients' usual lifestyles are hampered by their loss of movement and knee pain, necessitating the use of knee pain management and treatments right away. Mild knee discomfort merely causes inconvenience in daily life, however severe knee pain causes serious movement limitations. Damaged menisci, tendinitis, pseudogout, bursitis, and excess body weight are some of the other causes of knee pain.
The report on the global knee pain management market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Knee Pain Management Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Types (Acute Knee Pain and Chronic Knee Pain), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and E-commerce) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others |
Chronic Knee Pain segment is projected to account for a large market share
Based on types, the global knee pain management market is bifurcated into acute knee pain and chronic knee pain. The chronic knee pain segment is expected to account for a key share of the market during the forecast period due to an increase in the number of surgeries performed globally and an increase in the prevalence of chronic disorders that cause knee pain.
Hospital Pharmacies segment is expected to represent a key market share
On the basis of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, drug stores, and E-commerce. The hospital pharmacies segment is expected to constitute a key share of the market during the forecast period owing to the high number of patients visiting hospitals for knee pain treatments and the huge choice of knee pain treatments accessible in hospital pharmacy, hospital pharmacies accounted for the greatest proportion of the market, another significant benefit is the ease with which reimbursements can be obtained for purchases made at hospital pharmacies.
North America is anticipated to dominate the market
In terms of regions, the global knee pain management market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at a healthy CAGR during the forecast period. The regional market growth can be attributed to the increased incidence of knee arthritis, which includes knee osteoarthritis and rheumatoid arthritis, rise in healthcare spending, an increase in knee ligament injuries, and a demand for better treatment.
Segments Covered in the Report:
The global knee pain management market has been segmented based on
Types
Distribution Channels
Regions
Key Players
Leading manufacturers operating in the global knee pain management market include Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others.
Segments Covered in the Report:
The global knee pain management market has been segmented based on
Types
Distribution Channels
Regions
Key Players
Leading manufacturers operating in the global knee pain management market include Johnson & Johnson Services, Inc., F. Hoffman-La Roche AG, Amgen, Inc., Merck & Co., Inc., and Pfizer, Inc., Ferring B.V., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Sanofi S.A., Zydus Cadila, and Others.
Some other reports from this category!